Prolonged Corrected QT Interval in Patients with Myotonic Dystrophy Type 1

被引:3
|
作者
Park, Kang Min [1 ]
Shin, Kyong Jin [1 ]
Kim, Sung Eun [1 ]
Park, Jinse [1 ]
Ha, Sam Yeol [1 ]
Kim, Byoung Joon [2 ]
机构
[1] Inje Univ, Dept Neurol, Haeundae Paik Hosp, Pusan 612896, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Neurol, Seoul, South Korea
来源
JOURNAL OF CLINICAL NEUROLOGY | 2013年 / 9卷 / 03期
关键词
myotonic dystrophy; corrected QT interval; Bazett's formula; sudden cardiac death; CTG TRINUCLEOTIDE REPEAT; CARDIAC ABNORMALITIES; SUDDEN-DEATH; SIZE; INVOLVEMENT; EXPANSION; DISEASE; HEART; DISPERSION; PHENOTYPE;
D O I
10.3988/jcn.2013.9.3.186
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose Sudden cardiac death is one of the leading causes of death in patients with myotonic dystrophy type 1 (DM1). It has been proposed that a prolonged QT interval is associated with sudden cardiac death in several neurological diseases, including multiple system atrophy, idiopathic Parkinson's disease, and diabetic autonomic neuropathy. However, analyses of the corrected QT (QTc) interval in DM1 patients are rare in the literature. The purposes of this study were to determine the association between the QT interval and DM1, and the affecting factors. Methods Thirty-nine patients diagnosed with DM1 through genetic testing were enrolled. The QTc interval (calculated using Bazett's formula: QTc=QT/root RR) was compared between these patients and 39 normal healthy controls. The clinical and laboratory factors affecting QTc interval in the patient group were investigated. Results The QTc interval was significantly longer in the DM1 group (411.2 +/- 44.7 msec, mean +/- SD) than in the normal control group (355.6 +/- 20.6 msec). Intragroup analysis revealed that a prolonged QTc interval in DM1 patients was associated with being female and older, having a longer disease duration, and exhibiting abnormal electrocardiography findings. Conclusions The higher incidence of sudden cardiac death in the DM1 population is associated with the observed prolonged QTc interval in those patients.
引用
收藏
页码:186 / 191
页数:6
相关论文
共 50 条
  • [41] Risk of Prolonged Corrected QT Interval With Amisulpride Therapy for Renal Function Management in Patients With Schizophrenia
    Chen, Binbin
    Wang, Chen
    Xu, Xiangzhen
    Lyu, Haiyan
    Ma, Chunling
    Cheng, Gang
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (05) : 482 - 486
  • [42] Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
    Vladan M. Ninkovic
    Srdjan M. Ninkovic
    Vanja Miloradovic
    Dejan Stanojevic
    Marijana Babic
    Vojislav Giga
    Milan Dobric
    Michael I. Trenell
    Nebojsa Lalic
    Petar M. Seferovic
    Djordje G. Jakovljevic
    Acta Diabetologica, 2016, 53 : 737 - 744
  • [43] Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
    Ninkovic, Vladan M.
    Ninkovic, Srdjan M.
    Miloradovic, Vanja
    Stanojevic, Dejan
    Babic, Marijana
    Giga, Vojislav
    Dobric, Milan
    Trenell, Michael I.
    Lalic, Nebojsa
    Seferovic, Petar M.
    Jakovljevic, Djordje G.
    ACTA DIABETOLOGICA, 2016, 53 (05) : 737 - 744
  • [44] Hypogammaglobulinaemia and recurrent infections in patients with myotonic dystrophy type 1
    Stone, Rachael
    Baretto, Richard
    Duddridge, Michael
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 174 : 32 - 33
  • [45] Peripheral nerves involvement in patients with myotonic dystrophy type 1
    Peric, S.
    Nikolic, A.
    Kacar, A.
    Basta, I.
    Marjanovic, I.
    Lavrnic, D.
    Stevic, Z.
    Rakocevic-Stojanovic, V.
    JOURNAL OF NEUROLOGY, 2012, 259 : S205 - S205
  • [46] Endocrine function in 97 patients with myotonic dystrophy type 1
    M. C. Ørngreen
    P. Arlien-Søborg
    M. Duno
    J. M. Hertz
    J. Vissing
    Journal of Neurology, 2012, 259 : 912 - 920
  • [47] Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1
    Heatwole, Chad R.
    Miller, Jill
    Martens, Bill
    Moxley, Richard T., III
    ARCHIVES OF NEUROLOGY, 2006, 63 (08) : 1149 - 1153
  • [48] Endocrine function in 97 patients with myotonic dystrophy type 1
    Orngreen, M. C.
    Arlien-Soborg, P.
    Duno, M.
    Hertz, J. M.
    Vissing, J.
    JOURNAL OF NEUROLOGY, 2012, 259 (05) : 912 - 920
  • [49] Antioxidant imbalance in the erythrocytes of Myotonic dystrophy Type 1 patients
    Koc, Filiz
    Atli, Guluzar
    Menziletoglu, Sule Yildiz
    Kose, Sevgul
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2020, 680
  • [50] Sleep Disorders in Four Patients With Myotonic Dystrophy Type 1
    Urata, Yuka
    Nakamura, Masayuki
    Shiokawa, Nari
    Yasuniwa, Aiko
    Takamori, Nagisa
    Imamura, Kensuke
    Hayashi, Takehiro
    Ishizuka, Takanori
    Kasugai, Motofumi
    Sano, Akira
    FRONTIERS IN NEUROLOGY, 2020, 11